Literature DB >> 7856744

Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study.

J R Lopategui1, L H Sun, J K Chan, M J Gaffey, H F Frierson, C Glackin, L M Weiss.   

Abstract

Although cytogenetic data suggest that the t(2;5)-(p23;q35) translocation occurs in many cases of CD30+ lymphomas, the exact frequency of this event is still unknown. To clarify this issue and its epidemiological characteristics, we examined 37 formalin-fixed, paraffin-embedded specimens of CD30+ lymphomas from the United States and Hong Kong by reverse transcriptase-polymerase chain reaction (RT-PCR) for the status of the NPM and ALK genes, which are typically juxtaposed by the t(2;5) translocation. Thirty-four cases were classified as anaplastic large cell lymphomas (ALCL), 2 cases as non-anaplastic large cell lymphomas (LCL), and 1 case as the small cell variant of CD30+ lymphoma. The t(2;5) translocation was detected in 6 cases (16%), including 3 of 18 American patients and 3 of 19 cases from Hong Kong. All cases had a 185-bp NPM RT-PCR product as detected by Southern blot analysis, indicating adequate preservation of mRNA. The 6 positive cases were among 4 of 34 adult lymphomas, as compared with 2 of 3 childhood cases. Five of 17 T-lineage cases were t(2;5)-positive, compared with 1 of 15 B-lineage cases and none of the 5 null-cell or mixed lineage cases. Our results therefore show that t(2;5) occurs at a low frequency among CD30+ lymphomas, at least in our adult-dominated series.

Entities:  

Mesh:

Year:  1995        PMID: 7856744      PMCID: PMC1869852     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.

Authors:  R Morgan; S D Smith; B K Hecht; V Christy; J D Mellentin; R Warnke; M L Cleary
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

2.  Malignant histiocytosis: a specific t(2;5)(p23;q35) translocation? Review of the literature.

Authors:  E Benz-Lemoine; A Brizard; J L Huret; P Babin; F Guilhot; D Couet; J Tanzer
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

3.  T-cell receptor gene rearrangement in regressing atypical histiocytosis.

Authors:  J T Headington; M S Roth; D Ginsburg; A S Lichter; D Hyder; B Schnitzer
Journal:  Arch Dermatol       Date:  1987-09

4.  A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').

Authors:  R Rimokh; J P Magaud; F Berger; J Samarut; B Coiffier; D Germain; D Y Mason
Journal:  Br J Haematol       Date:  1989-01       Impact factor: 6.998

5.  A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis.

Authors:  Y Kaneko; G Frizzera; S Edamura; N Maseki; M Sakurai; Y Komada; M Sakurai; H Tanaka; M Sasaki; T Suchi
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

6.  CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.

Authors:  D Y Mason; C Bastard; R Rimokh; N Dastugue; J L Huret; U Kristoffersson; J P Magaud; C Nezelof; H Tilly; J P Vannier
Journal:  Br J Haematol       Date:  1990-02       Impact factor: 6.998

7.  The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.

Authors:  M M Le Beau; M A Bitter; R A Larson; L A Doane; E D Ellis; W A Franklin; C M Rubin; M E Kadin; J W Vardiman
Journal:  Leukemia       Date:  1989-12       Impact factor: 11.528

8.  A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene.

Authors:  P Fischer; E Nacheva; D Y Mason; P D Sherrington; C Hoyle; F G Hayhoe; A Karpas
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

9.  Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.

Authors:  F Bullrich; S W Morris; M Hummel; S Pileri; H Stein; C M Croce
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

Review 10.  Classification of primary cutaneous T-cell lymphomas.

Authors:  R Willemze; R C Beljaards; C J Meijer
Journal:  Histopathology       Date:  1994-05       Impact factor: 5.087

View more
  5 in total

1.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

Authors:  S Pittaluga; I Wlodarska; K Pulford; E Campo; S W Morris; H Van den Berghe; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

Authors:  B Falini; B Bigerna; M Fizzotti; K Pulford; S A Pileri; G Delsol; A Carbone; M Paulli; U Magrini; F Menestrina; R Giardini; S Pilotti; A Mezzelani; B Ugolini; M Billi; A Pucciarini; R Pacini; P G Pelicci; L Flenghi
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.

Authors:  S A Pileri; K Pulford; S Mori; D Y Mason; E Sabattini; G Roncador; M Piccioli; C Ceccarelli; P P Piccaluga; D Santini; O Leone; H Stein; B Falini
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.

Authors:  M Beylot-Barry; L Lamant; B Vergier; A de Muret; S Fraitag; B Delord; P Dubus; L Vaillant; M Delaunay; G MacGrogan; C Beylot; A de Mascarel; G Delsol; J P Merlio
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 5.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.